Corvus Pharmaceuticals CRVS Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's operating lease ROU assets?
- Corvus Pharmaceuticals (CRVS) reported operating lease ROU assets of $751K in Q1 2026.
- How has Corvus Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Corvus Pharmaceuticals's operating lease ROU assets decreased by 31.4% year-over-year, from $1.1M to $751K.
- What is the long-term trend for Corvus Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's operating lease ROU assets has grown at a -12.6% compound annual growth rate (CAGR), from $1.65M to $839K.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.